Indices
FIDSON
| Price | Today's Change | Avg daily Volume | 1 Year Change | 52 Week Range |
|---|---|---|---|---|
| 34.95 | 3.15 (9.91%) | 792.43K | 20.40 (140.21%) | 12.40 - 34.95 |
Data in real-time, as of 6/12/2025 11:11:07 AM
3 Months Trend
Profile
Fidson Healthcare Plc engages in the manufacture and distribution of pharmaceutical products in Nigeria. The company offers pharmaceutical products in various therapeutic areas, such as anti-infective, anti-arthritis, endocrinology, gastro-intestine, anti-retroviral, anti-malaria, cardiovascular, anti-depressant, pain relievers, haematinics, cough expectorants, and consumer goods. Its principal products include Biosulin-N, which is an anti-diabetic insulin; Gascol for heartburn, indigestion, dyspepsia, flatulence, and other acid-related disorders; Asomex 2.5 for acute uncomplicated UTI, complicated UTI, enteric fever, bone and joint infections, and adnexitis and prostatitis2; and Cutenox for the prevention of thrombosis in hospitalized medical and surgical patients. The company also offers Flutex for patients with depressive disorder, obsessive compulsive disorders, and bulima nervosa; Ciprotab 500, a second generation fluoroquinolone antibiotic for the treatment of various infections; ZETGEL to relieve pain in osteoarthrtis; and Astyfer Blood Builder for use in pregnancy, lactation, anaemia, haemorrhoids, anal fissures, chronic gastric ulcers, and iron deficiency; and Tuxil-C cough expectorant. In addition, it provides Formula 103, a razor less hair removal for men and women; baby diapers under Cuddles name; and tissue products under Fluffy brand. The company was incorporated in 1995 and is headquartered in Lagos, Nigeria. Website: www.fidson.com Founded in: 1995
Quotes
| LClose | 31.80 | Price | 34.95 |
|---|---|---|---|
| Change | 3.15 (9.91%) | Low | 34.90 |
| High | 34.95 | EPS | 0.64 |
| 52WkHigh | 34.95 | 52WkLow | 12.40 |
| 50d Mov Avg | 23.53 | 200d Mov Avg | 17.99 |
| AvgDlyVol | 792.43K | 3MthChg | 16.00 (84.43%) |
| 6MthChg | 20.45 (141.03%) | 12MthChg | 20.40 (140.21%) |
| Beta | 0.2481931 | Risk Factor | 0.006294806 |
| PE | 22.54 | Shares Outs. | 2.29B |
| Div. Yield | 4.14 | Market Cap | 80.21B |
| Volume | 2.66M | # Of Trades | 176 |
| Trades Value | 91.45M | ||
| Sector | Pharmaceuticals | ||
Income statement
Statement of Comprehensive Income as at
31-Mar-2018
| Name | Amount |
|---|---|
| Revenue | 16,229,903.00 |
| Profit before taxation | 160,867.00 |
| Taxation | 258,314.00 |
| Profit after tax | -97,447.00 |
| Transfer to revenue reserve | -322,447.00 |
| Profit attributable to: | |
| Owners of the company | -97,447.00 |
| Non-controlling interest | |
| Earnings per 50k share (k) | -6.00 |
| Net assets per 50k share (k) | 477.00 |
Board of directors
| Name | Title |
|---|---|
| Felix Ohiwerei | Chairman of the Board |
| Fidelis Ayebae | Chief Executive Officer/ Managing Director, Director |
| Olatunde Olanipekun | Finance Director, Executive Director |
| Abiola Adebayo | Operations Director, Executive Director |
| Olugbenga Olayeye | Executive Director, Sales and Marketing Director |
| Abayomi Adebanyo | Company Secretary |
| Olufunmilola Ayebae | Non-Executive Director |
| Emmanuel Imoagene | Non-Executive Director |
| Aishatu Sadauki | Non-Executive Director |
Currency
| Currency | Rate(₦) |
|---|---|
| USD USD/NGN | 1,545.97 |
| GBP GBP/NGN | 2,088.22 |
| EUR EUR/NGN | 1,768.22 |
| JPY JPY/NGN | 10.67 |
| CAD CAD/NGN | 1,131.05 |
| CNY CNY/NGN | 215.30 |
| AUD AUD/NGN | 1,009.36 |
| XOF XOF/NGN | 2.70 |
| XAF XAF/NGN | 2.70 |
| GHS GHS/NGN | 150.88 |
| AED AED/NGN | 420.93 |
| ZAR ZAR/NGN | 87.32 |
| JPY JPY/NGN | 10.67 |
| KES KES/NGN | 11.96 |
| EGP EGP/NGN | 31.21 |
| INR INR/NGN | 18.05 |
| AUD AUD/NGN | 1,009.36 |
| CHF CHF/NGN | 1,880.59 |
| DZD DZD/NGN | 11.76 |
| MAD MAD/NGN | 168.80 |
| AOA AOA/NGN | 1.69 |
| TZS TZS/NGN | 0.59 |
| BWP BWP/NGN | 115.78 |
| ETB ETB/NGN | 11.38 |
| NAD NAD/NGN | 87.23 |
| SDG SDG/NGN | 2.57 |
| MZN MZN/NGN | 24.17 |
| SLL SLL/NGN | 0.07 |
| MWK MWK/NGN | 0.89 |
| GMD GMD/NGN | 21.77 |
| BIF BIF/NGN | 0.52 |
| GNF GNF/NGN | 0.18 |
| LRD LRD/NGN | 7.78 |
| SZL SZL/NGN | 87.27 |
| CVE CVE/NGN | 16.00 |
| RWF RWF/NGN | 1.08 |
| DJF DJF/NGN | 8.70 |
| ERN ERN/NGN | 103.06 |
| ZMW ZMW/NGN | 61.68 |
